Global High Intensity Focused Ultrasound (HIFU) Market Size, Share, Forecast Report, 2020-2027

High intensity focused ultrasound (HIFU) therapy kills cancer cells with high frequency sound waves. It can treat only a single tumor or a part of a large tumor and cannot be used to treat widespread tumors. Thus, the HIFU therapy is not suitable for the treatment of malignant tumor. This therapy is a novel, emergent and practices ultrasound waves that propagate through tissue media as energy carriers. HIFU therapy is a completely non-invasive technology that has great potential of tumor ablation, hemostasis, thrombolysis as well as targeted drug/gene delivery. The therapy is also used to treat prostate cancer using high frequency ultrasound energy. It is broadly used in the field of interventional oncology due to its non-invasiveness, sharp treatment margins, and low complication rates. Additionally, the use of the technology in combination of other therapeutic and diagnostic modalities, such as targeted drug/gene-delivery, robotic surgery, and molecular imaging is expected to grow and have a revolutionary clinical impact over the forecast period.
Key Players in the Global High Intensity Focused Ultrasound (HIFU) Therapy Market
Some of the key players in this market are Image Guided Therapy, EDAP TMS, SonaCare Medical, LLC, Theraclion, Chongqing Haifu Medical Technology Co., Ltd, Koninklijke Philips N.V., Shanghai A&S Co. LTD, Mianyang Sonic Electronic Ltd., Insightec, Alpinion Medical Systems, and FUS Instruments.
Segments
The global high intensity focused ultrasound (HIFU) therapy market is segmented on the basis of modality, which comprises of therapeutic ultrasound, hemostasis, lithotripsy, thrombolysis, immunomodulation, and others.

On the basis of the methods, the market is segmented into non-invasive method, and minimal invasive method.

On the basis of applications, the market is segmented into prostate cancer, uterine fibroids, neurological disorders, cosmetic medicine, and others.

On the basis of end users, the market is segmented into diagnostic centers, hospitals, research centers, and others.